Results 241 to 250 of about 28,512 (352)
Idiopathic granulomatous mastitis: Bridging multidisciplinary care through dermatologic expertise and treatment strategies. [PDF]
Nadelmann ER +3 more
europepmc +1 more source
ABSTRACT Background Early detection of melanoma significantly boosts patient survival rates. Deep learning has demonstrated dermatologist‐level accuracy in assessing pigmented skin lesions by analysing images at the pixel level. However, these neural networks may face challenges with ‘real‐life’ images due to limited training data and image artefacts ...
Marianne Zanchetta +15 more
wiley +1 more source
Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database. [PDF]
Wu YY +6 more
europepmc +1 more source
ABSTRACT Background There is a growing body of literature suggesting that GLP‐1 receptor agonists (GLP‐1RAs) may be associated with hair loss; however, primary literature is sparse. Additionally, it is not well‐established which types of hair loss may be associated with GLP‐1RA use. Objectives This study aims to assess associations between GLP‐1RAs and
Lauren M. Ching +2 more
wiley +1 more source
Dermatologic Adverse Events in Patients Receiving Duvelisib Single-Agent and Combination Therapies
Viviane Liao +5 more
openalex +2 more sources
Utilization of biodegradable polymeric materials as delivery agents in dermatology
Fiorenza Rancan +2 more
openalex +2 more sources
Mask-Induced Dermatitis Progressing to Chronic Seborrheic Inflammation: A Case Report. [PDF]
Bin Rakan M, Rakan M, Bin Rakan I.
europepmc +1 more source
Dupilumab Treatment in Pemphigus: A Report of Three Cases and Literature Review
ABSTRACT Pemphigus vulgaris (PV) and foliaceus (PF) are rare autoimmune blistering diseases traditionally treated with systemic corticosteroids, immunosuppressants, intravenous immunoglobulins, and rituximab. Nonetheless, a subset of patients remains refractory or has contraindications to these conventional therapies.
José Javier Mateos Rico +5 more
wiley +1 more source

